Elderly patients ( age @ years , ECOG performance Status @-@ ) with advanced non-small-cell lung cancer were randomized to receive docetaxel @ mg/m ( @ ) plus cisplatin @ mg/m ( @ ) on Day @ , @ and @ ( docetaxel plus cisplatin ) or docetaxel @ mg/m ( @ ) on the same schedule ( docetaxel ) .